Teva Pharmaceutical Industries Ltd (TEVA) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.193x

Based on the latest financial reports, Teva Pharmaceutical Industries Ltd (TEVA) has a cash flow conversion efficiency ratio of 0.193x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA1.53 Billion ≈ $4.10 Million USD) by net assets (ILA7.92 Billion ≈ $21.22 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Teva Pharmaceutical Industries Ltd - Cash Flow Conversion Efficiency Trend (1991–2025)

This chart illustrates how Teva Pharmaceutical Industries Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Teva Pharmaceutical Industries Ltd total liabilities for a breakdown of total debt and financial obligations.

Teva Pharmaceutical Industries Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Teva Pharmaceutical Industries Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
OceanFirst Financial Corp NASDAQ:OCFC	0.022x
Tiangong International Company Limited F:34T1	0.010x
Beijing Strong Biotechnologies Inc SHE:300406	0.046x
Mader Group Ltd AU:MAD	0.132x
Sivers IMA Holding AB ST:SIVE	-0.016x
Guizhou Gas Group Corporation Ltd Class A SHG:600903	-0.004x
Hangzhou Sunrise Technology Co Ltd SHE:300360	0.057x
Ningbo Dechang Electrical Machinery Made Co Ltd SHG:605555	-0.019x

Annual Cash Flow Conversion Efficiency for Teva Pharmaceutical Industries Ltd (1991–2025)

The table below shows the annual cash flow conversion efficiency of Teva Pharmaceutical Industries Ltd from 1991 to 2025. For the full company profile with market capitalisation and key ratios, see TEVA market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	ILA7.92 Billion ≈ $21.22 Million	ILA3.10 Billion ≈ $8.31 Million	0.392x	+79.59%
2024-12-31	ILA5.72 Billion ≈ $15.34 Million	ILA1.25 Billion ≈ $3.34 Million	0.218x	+29.50%
2023-12-31	ILA8.13 Billion ≈ $21.79 Million	ILA1.37 Billion ≈ $3.67 Million	0.168x	-7.98%
2022-12-31	ILA8.69 Billion ≈ $23.30 Million	ILA1.59 Billion ≈ $4.26 Million	0.183x	+157.78%
2021-12-31	ILA11.24 Billion ≈ $30.14 Million	ILA798.00 Million ≈ $2.14 Million	0.071x	-35.44%
2020-12-31	ILA11.06 Billion ≈ $29.65 Million	ILA1.22 Billion ≈ $3.26 Million	0.110x	+207.80%
2019-12-31	ILA15.06 Billion ≈ $40.38 Million	ILA538.00 Million ≈ $1.44 Million	0.036x	-76.94%
2018-12-31	ILA15.79 Billion ≈ $42.34 Million	ILA2.45 Billion ≈ $6.56 Million	0.155x	-17.22%
2017-12-31	ILA18.75 Billion ≈ $50.25 Million	ILA3.51 Billion ≈ $9.40 Million	0.187x	+25.30%
2016-12-31	ILA34.99 Billion ≈ $93.82 Million	ILA5.22 Billion ≈ $14.01 Million	0.149x	-19.37%
2015-12-31	ILA29.93 Billion ≈ $80.23 Million	ILA5.54 Billion ≈ $14.86 Million	0.185x	-15.64%
2014-12-31	ILA23.36 Billion ≈ $62.61 Million	ILA5.13 Billion ≈ $13.75 Million	0.220x	+53.51%
2013-12-31	ILA22.64 Billion ≈ $60.69 Million	ILA3.24 Billion ≈ $8.68 Million	0.143x	-28.48%
2012-12-31	ILA22.87 Billion ≈ $61.31 Million	ILA4.57 Billion ≈ $12.26 Million	0.200x	+8.06%
2011-12-31	ILA22.34 Billion ≈ $59.90 Million	ILA4.13 Billion ≈ $11.08 Million	0.185x	-1.57%
2010-12-31	ILA22.00 Billion ≈ $58.99 Million	ILA4.14 Billion ≈ $11.09 Million	0.188x	+7.33%
2009-12-31	ILA19.26 Billion ≈ $51.63 Million	ILA3.37 Billion ≈ $9.04 Million	0.175x	-11.32%
2008-12-31	ILA16.36 Billion ≈ $43.86 Million	ILA3.23 Billion ≈ $8.66 Million	0.197x	+49.89%
2007-12-31	ILA13.76 Billion ≈ $36.89 Million	ILA1.81 Billion ≈ $4.86 Million	0.132x	-28.44%
2006-12-31	ILA11.18 Billion ≈ $29.97 Million	ILA2.06 Billion ≈ $5.52 Million	0.184x	-18.68%
2005-12-31	ILA6.05 Billion ≈ $16.22 Million	ILA1.37 Billion ≈ $3.67 Million	0.226x	-2.09%
2004-12-31	ILA5.40 Billion ≈ $14.48 Million	ILA1.25 Billion ≈ $3.35 Million	0.231x	+21.65%
2003-12-31	ILA3.30 Billion ≈ $8.84 Million	ILA626.60 Million ≈ $1.68 Million	0.190x	-1.41%
2002-12-31	ILA1.83 Billion ≈ $4.92 Million	ILA353.70 Million ≈ $948.26K	0.193x	-2.38%
2001-12-31	ILA1.38 Billion ≈ $3.71 Million	ILA273.15 Million ≈ $732.30K	0.198x	+37.51%
2000-12-31	ILA1.15 Billion ≈ $3.09 Million	ILA165.63 Million ≈ $444.04K	0.144x	-30.58%
1999-12-31	ILA742.30 Million ≈ $1.99 Million	ILA153.61 Million ≈ $411.82K	0.207x	+94.44%
1998-12-31	ILA659.60 Million ≈ $1.77 Million	ILA70.20 Million ≈ $188.20K	0.106x	-66.31%
1997-12-31	ILA612.80 Million ≈ $1.64 Million	ILA193.60 Million ≈ $519.03K	0.316x	+2586.53%
1996-12-31	ILA535.20 Million ≈ $1.43 Million	ILA-6.80 Million ≈ $-18.23K	-0.013x	-104.91%
1995-12-31	ILA407.60 Million ≈ $1.09 Million	ILA105.40 Million ≈ $282.57K	0.259x	+131.78%
1994-12-31	ILA342.40 Million ≈ $917.96K	ILA38.20 Million ≈ $102.41K	0.112x	-20.72%
1993-12-31	ILA267.90 Million ≈ $718.23K	ILA37.70 Million ≈ $101.07K	0.141x	+11.33%
1992-12-31	ILA223.10 Million ≈ $598.12K	ILA28.20 Million ≈ $75.60K	0.126x	+154.19%
1991-12-31	ILA183.00 Million ≈ $490.62K	ILA9.10 Million ≈ $24.40K	0.050x	--

About Teva Pharmaceutical Industries Ltd

TA:TEVA Israel Drug Manufacturers - Specialty & Generic

Market Cap

$32.34 Billion

ILA12.06 Trillion ILA

Market Cap Rank

#8746 Global

#88 in Israel

Share Price

ILA10360.00

Change (1 day)

-1.33%

52-Week Range

ILA5374.00 - ILA11350.00

All Time High

ILA25447.60